Noticias de Eulerpool Hansa Biopharma

Hansa Biopharma Noticias de Acciones

Hansa Biopharma es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Hansa Biopharma.

• 11 de junio ·

  Yahoo
  Hansa Biopharma to attend BIO International Convention
• 14 de mayo ·

  Yahoo
  Hansa Biopharma data at the 2025 PNS Annual Meeting demonstrates potential of imlifidase in the treatment of GBS
• 24 de abril ·

  SeekingAlpha
  Hansa Biopharma AB (publ) (HNSBF) Q1 2025 Earnings Call Transcript
• 24 de abril ·

  SeekingAlpha
  Hansa Biopharma AB (publ) 2025 Q1 - Results - Earnings Call Presentation
• 6 de febrero ·

  SeekingAlpha
  Hansa Biopharma AB (HNSBF) Q4 2024 Earnings Call Transcript
• 7 de enero ·

  Yahoo
  Hansa Biopharma to attend 2025 J.P. Morgan Healthcare Conference
• 17 de diciembre ·

  Yahoo
  Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome
• 5 de diciembre ·

  Yahoo
  Hansa Biopharma Completes Enrolment in Global Pivotal Phase 3 Trial of imlifidase in Anti-Glomerular Basement Membrane Disease
• 3 de diciembre ·

  Yahoo
  Genethon and Hansa Biopharma Announce Initiation of a Phase 2 Trial of imlifidase as a Pre-Treatment to GNT-0003 in Severe Crigler-Najjar Syndrome
• 30 de octubre ·

  Yahoo
  Hansa Biopharma to Attend Truist Securities BioPharma Symposium